• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

mallinckrodt plc

  1. Open Letter from Mallinckrodt Investor Reporting Fraud Reported to U.S. Securities and Exchange Comm

    "Accounting Fraud, Bankruptcy Fraud, Insider Trading, Proxy Fraud, and Electoral Fraud - Mallinckrodt Plc." October 22, 2021, open letter to the U.S. Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/1567892/000106299321009816/exhibit99-2.htm October 22, 2021, open...
    • anonymous
    • Thread
    • fraud mallinckrodt mallinckrodt plc
    • Replies: 5
    • Forum: Mallinckrodt
Top Bottom
Back